VEGF Release from Platelets and Its Importance in Cancer
Author Information
Author(s): RE Banks, MA Forbes, SE Kinsey, A Stanley, E Ingham, C Walters, PJ Selby
Primary Institution: ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds, UK
Hypothesis
Is the higher concentration of VEGF in serum compared to plasma due to its release from platelets during coagulation?
Conclusion
The study found that serum VEGF concentrations are significantly higher than those in matched plasma due to the release of VEGF from activated platelets.
Supporting Evidence
- Serum VEGF concentrations ranged from 76 to 854 pg/ml.
- Matched plasma VEGF concentrations ranged from <9 to 42 pg/ml.
- Clotting of platelet-rich plasma resulted in higher VEGF levels of 38-505 pg/ml.
Takeaway
When blood clots, platelets release a substance called VEGF, which helps in forming new blood vessels. This is important for understanding how cancer spreads.
Methodology
Blood samples were taken from healthy volunteers, processed into serum and plasma, and VEGF levels were measured using ELISA.
Potential Biases
Potential bias due to the small sample size and the specific demographic of healthy volunteers.
Limitations
The study was limited to a small sample size of healthy volunteers and may not represent all populations.
Participant Demographics
Eight healthy volunteers aged between 21 and 56 years, both male and female.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website